Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin
- 1 June 2004
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (6) , 533-546
- https://doi.org/10.1016/j.ijantimicag.2004.02.017
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, SwedenClinical Microbiology & Infection, 2003
- Analysis of dual active fluoroquinolones in Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 2003
- Effects of an Efflux Mechanism and Ribosomal Mutations on Macrolide Susceptibility of Haemophilus influenzae Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Infectious etiologies in acute exacerbation of COPDDiagnostic Microbiology and Infectious Disease, 2001
- A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniae Isolates from across Europe, North America, and South AmericaAntimicrobial Agents and Chemotherapy, 2000
- Fluoroquinolone Resistance inStreptococcus pneumoniaeNew England Journal of Medicine, 1999
- Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751aJournal of Medical Microbiology, 1995
- The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Emergence of Multiply Resistant PneumococciNew England Journal of Medicine, 1978
- THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC LUNGSThe Journal of Experimental Medicine, 1942